AMEX · Healthcare · Medical Devices · USA
Myomo Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
Myomo Inc produces wearable robotic braces that restore arm and hand function in patients with neuromuscular paralysis. The MyoPro orthosis uses electromyography sensors to detect muscle signals and activate motors helping users move weakened limbs caused by stroke, spinal cord injury, brachial plexus damage, and other neurological conditions. Distribution channels include direct billing to patients, orthotic and prosthetic providers, and the Veterans Administration.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Myomo Inc stock.
Undervalued: intrinsic value $1.93 per share, market price $0.92, margin of safety 52.4% (as of 2026-11-17).
A 1.6x revenue multiple, discounted for its losses, values the shares at $1.93; the price of $0.92 is 52% below that value.
All 140 Medical Devices stocks
MYO is undervalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $1.93; the price of $0.92 is 52% below that value.
$1.93 per share (as of the 2026-11-17 close), against a market price of $0.92. That is a margin of safety of 52.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.